Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to ...

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1. Under the deal, cash-paying patients can access a month's supply ...

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, ...

Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...

A conservative Fox News pundit who has found himself at war with MAGA acolytes escalated that feud on Wednesday night, ...

While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

Weight Watchers, and all the similar programmes that sprang up in its wake had their own success stories. Many members reported finding a sense of community and accountability in their groups.

In 2020, Weight Watchers’ subscribers worldwide peaked at 5 million. Then the Covid-19 pandemic hit, resulting in a vast drop in members attending in-person meetings.

Weight Watchers as I knew it on and off for two decades worked by assigning each member a points limit per day, and assigning foods a points value based on their nutritional value.

Weight Watchers may have put a friendlier face on weight loss than the current Ozempic craze does, but it, too, was a business powered by the force of its customers’ self-disgust.

On Feb. 26, Winfrey notified Weight Watchers that she would not be standing for re-election as a member of the board at the company’s 2024 annual meeting of shareholders, per an SEC filing Thursday.